Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;19(3):74-6.

Giant myofibroblastoma of the male breast: a case report and literature review

Affiliations

Giant myofibroblastoma of the male breast: a case report and literature review

Kamal Kataria et al. Malays J Med Sci. 2012 Jul.

Abstract

Myofibroblastomas are soft-tissue neoplasms that are thought to arise from myofibroblasts. They are mostly observed in males 41-85 years of age; however, this lesion also occurs in women. The usual clinical presentation is a unilateral painless lump that is not adherent to overlying or underlying structures. Microscopically, myofibroblastomas can be divided into 5 subtypes: classical, epithelioid, collagenised, cellular, and infiltrative. Mammary ducts and lobules are absent in the typical histological subtypes and the adjacent breast parenchyma may form a pseudocapsule. The majority of myofibroblastomas are immunoreactive for CD34, desmin, smooth muscle actin, and vimentin and are negative for cytokeratin and S-100 protein. We present a case of a giant myofibroblastoma arising in the background of gynecomastia in an adult male.

Keywords: breast; gynecomastia; mesenchymal; myofibroblastoma; spindle cell.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
A large, pendulous right breast.
Figure 2:
Figure 2:
Haphazardly arranged short fascicles of oval-to-spindle-shaped cells separated by thick eosinophilic collagen bands (haematoxylin and eosin staining, 400 × magnification).
Figure 3:
Figure 3:
(A) Thick collagen bands, Masson’s trichrome stain (200 × magnification). (B) Tumour cells immunopositive for vimentin (200 × magnification). (C) CD34 immunopositivity in tumour cells (200 × magnifications). (D) Tumour cells immunopositive for BCL2 (200 × magnification).

References

    1. Schurch W, Seemayer TA, Gabbiani G. The myofibroblast: A quarter century after its discovery. Am J Surg Pathol. 1998;22(2):141–147. - PubMed
    1. Wargotz ES, Weiss SW, Norris HJ. Myofibroblastoma of breast: 16 cases of a distinctive benign mesenchymal tumour. Am J Surg Pathol. 1987;11(7):493–502. - PubMed
    1. Arsenovic N, Abdulla KE, Shamim KS. Mammarytype myofibroblastoma of soft tissue. Indian J Pathol Microbiol. 2011;54(2):391–393. - PubMed
    1. Ali S, Teichberg S, Derisi DC, Urmacher C. Giant myofibroblastoma of the male breast. A case report. Am J Surg Pathol. 1994;18(11):1170–1176. - PubMed
    1. Fihlo JSR, Faoro LN, Gasparetto EL, Totsugui JT, Schmitt FC. Mammary epithelioid myofibroblastoma arising in bilateral gynecomastia: Case report with immunohistochemical profile. Int J Surg Pathol. 2001;9(4):331–334. - PubMed

LinkOut - more resources